ComforCleanse laxative recalled over improper warning labelling
>
Urgent recall issued for common drugs, after critical warning for pregnant women and babies was found to be missing
- Popular laxative recalled by the ACCC for inadequate warning labels on its bottles
- ComforCleanse is sold as a “high-powered herbal formula” for healthy colon function.
- Product is currently marked ‘out of stock’ in stores as changes are made
<!–
<!–
<!–<!–
<!–
<!–
<!–
A popular laxative has been withdrawn from the market over fears that it was mislabeled and could be potentially dangerous to children and pregnant women.
The Australian Competition and Consumer Commission and Therapeutic Goods Administration have withdrawn ComforCleanse from the market.
The Young Living Essential Oils product claims to be a “high-powered herbal formula that supports normal digestive and colonic function.”
A popular laxative has been withdrawn from the market over fears that it was mislabeled and could potentially be dangerous to children and pregnant women.
However, the report said the packaging did not include “mandatory wording for required label warnings” for the ingredient fennel, which also goes by its scientific name, Foeniculum vulgate.
The advisory states that all products with an expiration date of March 29, 2023, or bottles bearing the identification numbers: ‘Lot 15500101’, must be returned to Young Living for a refund.
Currently, the product is marked as ‘not available for purchase’ in your online store.
The TGA also states that Young Living will contact customers in its database with the recall information and that the products in the warehouse have been segregated and relabeled.
Known for selling essential oils and alternative remedies, Young Living is a multi-marketing marketing company that originated in Utah, United States.
Although customers can purchase the products through their online store, they are known for their ‘Brand Partner’ program.
In July 2022, the US Food and Drug Association (FDA) issued a warning to its US division after discovering that brand partners were making pharmaceutical claims with its essential oils.
The Young Living Essential Oils product claims to be a “high-powered herbal formula that supports normal digestive and colonic function.”
Some Young Living members said that lemon essential oil had been shown to be “as effective as chanca piedra pills in breaking up kidney stones,” as well as claimed that frankincense essential oil could help with arthritis and asthma.
Addressing the FDA’s warning letter, Young Living said the partners who made these statements went against their “policies and procedures.”
“Young Living takes FDA complaints very seriously, and in the event of a complaint, our Conduct Success team follows the three-step compliance approach with Brand Partners where we educate, warn, and if compliance is not met appropriate warnings, it will then proceed with account termination,” the statement said.